To determine whether PDCD11 is a potential target for the treatment of p53‐mutant breast and colon cancers, MDA‐MB‐231 and HT‐29 cells stably and inducibly expressing shRNAs were inoculated into nude mice. Here, TP53 is linked to colonic neoplasm.